首页 › 基金 › SUPERSTRING CAPITAL MANAGEMENT LP › ACRS
SUPERSTRING CAPITAL MANAGEMENT LP 对 ACRS 的持仓历史
ACLARIS THERAPEUTICS INC · 医疗保健
SUPERSTRING CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 ACRS(ACLARIS THERAPEUTICS INC)257,675 股,市值约 US$1.4M,约占其申报组合的 0.86%,在其申报持仓中市值排名第 23 位。 SUPERSTRING CAPITAL MANAGEMENT LP 最近 2 个申报季度中有 2 个季度披露了 ACRS 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SUPERSTRING CAPITAL MANAGEMENT LP 对 ACRS 的持仓演变
SUPERSTRING CAPITAL MANAGEMENT LP 于 Q1 2026 首次披露 ACRS 持仓:366,490 股(约 US$1.4M)。 在 2 次申报中,SUPERSTRING CAPITAL MANAGEMENT LP 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 257,675 股、市值约 US$1.4M,环比减持 -108,815 股。。 持仓曾出现大幅变动:Q2 2026 减持约 30% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 366.49K | $1.37M | 新进 |
| Q2 2026 | 257.68K | $1.36M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ACRS 与 13F 数据
ACRS(ACLARIS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 ACRS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$63.3M), Deep Track Capital, LP (US$49.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ACRS 的基金
- RA CAPITAL MANAGEMENT, L.P. 12.72M 股 · $67.30M · Q2 2026
- BML Capital Management, LLC 11.97M 股 · $63.35M · Q2 2026
- Deep Track Capital, LP 9.35M 股 · $49.44M · Q2 2026
- Vivo Capital, LLC 6.69M 股 · $35.41M · Q2 2026
- Frazier Life Sciences Management, L.P. 4.93M 股 · $26.06M · Q2 2026
- Rock Springs Capital Management LP 4.33M 股 · $22.91M · Q2 2026
- Decheng Capital LLC 4.04M 股 · $21.38M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.95M 股 · $10.30M · Q2 2026
- Kalehua Capital Management LLC 1.83M 股 · $9.69M · Q2 2026
- Jones Hill Capital LP 1.76M 股 · $9.31M · Q2 2026
- Palo Alto Investors LP 1.61M 股 · $8.54M · Q2 2026
- MPM BioImpact LLC 1.04M 股 · $5.51M · Q2 2026
更多关于 SUPERSTRING CAPITAL MANAGEMENT LP
常见问题
How long has SUPERSTRING CAPITAL MANAGEMENT LP held ACRS?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in ACRS?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 257.68K shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $1.36M, representing 0.86% of its reported portfolio and ranking #23.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling ACRS?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP reduced its position in ACRS.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.